Evidence supporting the use of: N-acetyl-cysteine (NAC)
For the health condition: Autoimmune Disorders

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

N-acetyl-cysteine (NAC) is primarily justified by scientific rationale for use in autoimmune disorders, though the clinical evidence remains limited and preliminary. NAC acts as a precursor to glutathione, one of the body's most important endogenous antioxidants. In autoimmune conditions, oxidative stress and inflammation are often elevated, contributing to tissue damage and disease progression. Scientific studies, mainly in animal models and in vitro experiments, suggest that NAC can modulate immune function, reduce oxidative stress, and decrease the production of pro-inflammatory cytokines. For example, research in models of systemic lupus erythematosus (SLE) and rheumatoid arthritis indicates that NAC supplementation can reduce disease severity and restore redox balance. Some small-scale human studies have explored NAC’s effects in conditions like SLE and Sjögren's syndrome, showing potential benefits such as reduced fatigue and lowered markers of oxidative stress. However, these studies are limited by small sample sizes, short durations, and methodological weaknesses. There is not yet robust, high-quality clinical trial data supporting NAC’s widespread use for autoimmune diseases. Major health authorities do not currently endorse NAC as a standard treatment for autoimmune disorders. In summary, while there is a plausible biochemical rationale and some early evidence, the clinical support for NAC in autoimmune disorders is weak and warrants further research.

More about N-acetyl-cysteine (NAC)
More about Autoimmune Disorders